Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP1 | P22413 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
| ▸ | KIF11 | P52732 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5952865 | 0.91 | — | — | |
| SCHEMBL5837577 | 0.89 | HTR1A (0.34) | — | |
| SCHEMBL5951591 | 0.89 | ENPP1 (0.32) | ENPP1BACE1DRD2JAK2KIF11 | |
| SCHEMBL273374 | 0.89 | BRD4 (0.31) | — | |
| SCHEMBL5836947 | 0.88 | RORC (0.36) | — | |
| SCHEMBL6065061 | 0.87 | BACE1 (0.32) | BACE1DRD2JAK2KIF11 | |
| SCHEMBL5952016 | 0.86 | HTR2C (0.32) | — | |
| SCHEMBL141357 | 0.86 | — | — | |
| SCHEMBL5952255 | 0.86 | DRD2 (0.34) | ENPP1BACE1DRD2 | |
| SCHEMBL2512916 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060166813-A1 | Preparation of supported catalyst systems | BASELL POLYOLEFINE GMBH (DE) | 2006-07-27 | — | — | US | claimed |
| EP-2576642-B1 | PROCESS FOR PREPARING A SUPPORTED CATALYST SYSTEM FOR OLEFIN POLYMERIZATION, THE CATALYST SYSTEM AND ITS USE | BASELL POLYOLEFINE GMBH (DE) | 2017-08-16 | — | — | EP | disclosed |
| EP-2513166-B1 | PROCESS FOR THE PREPARATION OF SUPPORTED CATALYSTS | BASELL POLYOLEFINE GMBH (DE) | 2017-04-05 | — | — | EP | disclosed |
| EP-1824888-B1 | MONOCYCLOPENTADIENYL COMPLEXES | BASELL POLYOLEFINE GMBH (DE) | 2017-01-18 | — | — | EP | disclosed |
| US-8999875-B2 | Process for preparing a supported catalyst system for olefin polymerization, the catalyst system and its use | BASELL POLYOLEFINE GMBH (DE) | 2015-04-07 | — | — | US | disclosed |
| EP-2415792-B1 | COPOLYMER OF OLEFIN AND CONJUGATED DIENE, AND PROCESS FOR PRODUCING SAME | MITSUI CHEMICALS INC (JP) | 2014-11-12 | — | — | EP | disclosed |
| EP-1740626-B1 | CATALYST SYSTEM FOR OLEFIN POLYMERIZATION, ITS PRODUCTION AND USE | BASELL POLYOLEFINE GMBH (DE) | 2014-10-22 | — | — | EP | disclosed |
| US-8859451-B2 | Process for the preparation of supported catalysts | BASELL POLYOLEFINE GMBH (DE) | 2014-10-14 | — | — | US | disclosed |
| US-8680001-B2 | Preparation of supported catalyst systems containing reduced amounts of aluminoxanes | BASELL POLYOLEFINE GMBH (DE) | 2014-03-25 | — | — | US | disclosed |
| US-8664140-B2 | Catalyst system for olefin polymerization, its production and use | BASELL POLYOLEFINE GMBH (DE) | 2014-03-04 | — | — | US | disclosed |
| WO-2004018489-A1 | MONOCYCLOPENTADIENYL COMPLEXES | BASELL POLYOLEFINE GMBH (DE) | 2004-03-04 | — | — | WO | disclosed |
| US-20040033890-A1 | Catalyst system for carrying out olefin polymerization comprising a calcined hydro-talcite serving as a supporting material | LYONDELL CHEMICAL TECHNOLOGY, L.P. | 2004-02-19 | — | — | US | disclosed |
| WO-2004007569-A1 | PREPARATION OF CATALYST SYSTEMS | BASELL POLYOLEFINE GMBH (DE) | 2004-01-22 | — | — | WO | disclosed |
| US-20030176275-A1 | Catalytic solid supported on calcined hydrotalcite for olefinic polymerisation | BASELL POLYOLEFINE GMBH (DE) | 2003-09-18 | — | — | US | disclosed |
| US-20030078340-A1 | Impregnating a mechanically fluidized porous particulate support material with a catalyst and polymerizing monomer(s) to produce polymer; heating mixture antioxidants, ultraviolet radiation stabilizer, diluent and metal stearate; depositing | BOREALIS TECHNOLOGY OY (FI) | 2003-04-24 | — | — | US | disclosed |
| US-20030009046-A1 | Preparation of preparing substituted indanones | EQUISTAR CHEMICALS, LP | 2003-01-09 | — | — | US | disclosed |
| EP-0653433-B1 | Novel transition metal compound, olefin polymerization catalyst component comprising the transition metal compound, olefin polymerization catalyst comprising the olefin polymerization catalyst component, and process for olefin polymerization | MITSUI CHEMICALS INC (JP) | 1999-01-13 | — | — | EP | disclosed |
| US-5859272-A | METALLOCENES; PRODUCES POLYOLEFINS HAVING A HIGH MELTING POINT AND A HIGH MOLECULAR WEIGHT; HIGH POLYMERIZATION ACTIVITY | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1999-01-12 | — | — | US | disclosed |
| US-5616663-A | TRANSITION METAL COMPOUND, ALUMINOXANE, COMPOUND WHICH REACTS WITH TRANSITION METAL COMPOUND TO FORM ION PAIR | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1997-04-01 | — | — | US | disclosed |
| EP-0653433-A1 | Novel transition metal compound, olefin polymerization catalyst component comprising the transition metal compound, olefin polymerization catalyst comprising the olefin polymerization catalyst component, and process for olefin polymerization | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1995-05-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030009046-A1 | Preparation of preparing substituted indanones | CYP1A2, CYP1B1, CYP1A1 | ENPP1 4183/4885BACE1 1435/4885DRD2 1860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.